Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,716.09
(
0.25%
)
US TECH 100
24,130.00
(
0.48%
)
Dow Jones
46,993.26
(
0.10%
)
Brent Oil
99.40
(
-1.25%
)
Bitcoin
74,634.86
(
0.94%
)
News Focus
News Focus
Post# of 257253
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 842
Posts 122793
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 70176

Friday, 06/05/2009 2:56:55 PM

Friday, June 05, 2009 2:56:55 PM

Post# of 257253
ABT and AZN submit NDA for Certriad, a combination of Crestor and TriLipix:

http://finance.yahoo.com/news/Abbott-and-AstraZeneca-Submit-prnews-15436198.html

This combo pill has the potential to be a very big-selling product, IMO.

ABT and AZN are also co-promoting Crestor and TriLipix as individual drugs; the co-promotion agreement for Crestor was inked in Aug 2008, while the co-promotion agreement for TriLipix was signed yesterday. Financial terms have not been disclosed.


“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now